| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 55224-05-0 | 環(huán)酯紅霉素; 大威霉素 | Davercin; Erythromycin A cyclic 11,12-carbonate; (1R,2R,5R,6S,7S,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-Dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-hydroxy-6-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-1,5,7,9,11,13-hexamethyl-3,15,17-trioxabicyclo[12.3.0]heptadecane-4,12,16-trione |  | C38H65NO14 | 詳情 | 供應(yīng)商 |
| 148054-14-2 | L-Isoleucinamide,L-leucyl-L-seryl-L-seryl-L-phenylalanyl-L-valyl-L-arginyl- (9CI); 16: PN:WO0114883 SEQID: 28 claimed protein |  | C38H65N11O9 | 詳情 | 供應(yīng)商 | |
| 78740-70-2 | Tylosin,4A-O-de(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-6-de(2-oxoethyl)-6-methyl- (9CI); Oxacyclohexadecane,tylosin deriv.; 19-Deformyldesmycosin; TMC 014 |  | C38H65NO13 | 詳情 | 供應(yīng)商 | |
| 62258-12-2 | GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC; LACTO-N-DIFUCOHEXAOSE-2; LACTO-N-DIFUCOSYLHEXAOSE II; LACTO-N-DIFUCOHEXAOSE II; LDFH II; LND-2; LNDFH II; BETA-D-GAL-[1->3]-(ALPHA-L-FUC-[1->4])-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-D-GLC; GAL-BETA1,3(FUC-ALPHA1,4)GLCNAC-BETA1,3GAL-BETA1,4(FUC-ALPHA1,3)GLC |  | C38H65NO29 | 詳情 | 供應(yīng)商 | |
| 62469-99-2 | ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC; ALPHA-FUC-[1->2]-BETA-GAL-[1->4][ALPHA-FUC-(1->3)]-BETA-GLCNAC-[1->3]-BETA-GAL-[1->4]-GLC; LACTO-N-NEO-DIFUCOHEXAOSE I; LEWIS Y HEXASACCHARIDE; LEY-LACTOSE; α-fuc-(1→2)-β-gal-(1→4)(α-fuc-[1→3])-β-glcnac-(1→3)-β-gal-(1→4)-glc; Lacto-N-neo-difucohexaoseI, Ley-lactose, α-Fuc-(1-2)-β-Gal-(1-4)(α-Fuc-[1-3])-β-GlcNAc-(1-3)-β-Gal-(1-4)-Glc | 無 | C38H65NO29 | 詳情 | 供應(yīng)商 |